Literature DB >> 8601927

Prepregnant weight in relation to risk of neural tube defects.

M M Werler1, C Louik, S Shapiro, A A Mitchell.   

Abstract

OBJECTIVE: To examine the relation between prepregnant weight and the risk of neural tube defects (NTDs).
DESIGN: Data were collected from 1988 to 1994 in a case-control surveillance program of birth defects.
SETTING: Study subjects were ascertained at tertiary care centers and birth hospitals in the greater metropolitan areas of Boston, Mass, and Philadelphia, Pa, and in southeastern Ontario. PARTICIPANTS: Cases were 604 fetuses or infants with an NTD identified within 6 months of delivery. Controls were 1658 fetuses or infants with other major malformations identified within 6 months of delivery. For 1992 to 1994, there were 93 control infants without major malformations. MAIN OUTCOME MEASURE: Relative risk of NTDs in infants or fetuses for different maternal weights.
RESULTS: Relative to women who weighed 50 to 59 kg, risk of NTDs increased from 1.9 (95% confidence interval [CI], 1.2 to 2.9) for women weighing 80 to 89 kg to 4.0 (95% CI, 1.6 to 9.9) for women weighing 110 kg or more. When women were classified according to daily intake above or below the recommended level of 400 micrograms of folate, approximate threefold increases in risk were estimated for the heaviest weights in both groups. Intakes of 400 micrograms of folate or more reduced risk of NTDs by 40% among women weighing less than 70 kg, but no risk reduction was observed among heavier women.
CONCLUSION: The risk of NTDs increased with increasing prepregnant weight, independent of the effects of folate intake.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601927     DOI: 10.1001/jama.1996.03530380031027

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  52 in total

1.  Maternal obesity and risk of neural tube defects.

Authors:  G Koren
Journal:  Can Fam Physician       Date:  2001-07       Impact factor: 3.275

2.  Fetal serum folate concentrations and placental folate transport in obese women.

Authors:  Margaret F Carter; Theresa L Powell; Cun Li; Leslie Myatt; Donald Dudley; Peter Nathanielsz; Thomas Jansson
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

3.  Are epidemiological approaches suitable to study risk/preventive factors for human birth defects?

Authors:  Sonia Hernandez-Diaz; Anna Sara Oberg
Journal:  Curr Epidemiol Rep       Date:  2015-03

4.  Body mass index and serum folate in childbearing age women.

Authors:  Ramin Mojtabai
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  Acephalous lamb from an in vitro-produced sheep embryo.

Authors:  Abolfazl Shirazi; Ebrahim Ahmadi; Majid Jadidi; Naser Shams-Esfandabadi; Banafsheh Heidari
Journal:  Can Vet J       Date:  2009-05       Impact factor: 1.008

6.  Physical activity and risk of neural tube defects.

Authors:  Suzan L Carmichael; Gary M Shaw; Eric Neri; Donna M Schaffer; Steve Selvin
Journal:  Matern Child Health J       Date:  2002-09

7.  Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects.

Authors:  T I Chang; M Horal; S K Jain; F Wang; R Patel; M R Loeken
Journal:  Diabetologia       Date:  2003-03-26       Impact factor: 10.122

8.  The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida.

Authors:  Samantha E Parker; Mahsa M Yazdy; Sarah C Tinker; Allen A Mitchell; Martha M Werler
Journal:  Am J Obstet Gynecol       Date:  2013-05-24       Impact factor: 8.661

9.  Maternal ethnicity and risk of neural tube defects: a population-based study.

Authors:  Joel G Ray; Marian J Vermeulen; Chris Meier; David E C Cole; Philip R Wyatt
Journal:  CMAJ       Date:  2004-08-17       Impact factor: 8.262

10.  The methylenetetrahydrofolate reductase C677T genotype and the risk of obesity in three large population-based cohorts.

Authors:  Sarah J Lewis; Debbie A Lawlor; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Shah Ebrahim; Jeppe Zacho; Andy Ness; Sam Leary; George Davey Smith
Journal:  Eur J Endocrinol       Date:  2008-04-21       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.